Loading...
Projects source: E-CRIS

Magnetic and radionuclide labeled nanostructured materials for medical applications

Research activity

Code Science Field
P000  Natural sciences and mathematics   
Keywords
Nanostructures, Nanocrystallography, Nanomagnetism, Nanomedicine, Radionuclides, Radiopharmaceutics
Organisations (5) , Researchers (1)
0094  University of Belgrade, Vinča Institute of Nuclear Sciences - National Institute of the Republic of Serbia
no. Code Name and surname Research area Role Period No. of publicationsNo. of publications
1.  08671  Vojislav Spasojević  Condensed matter: electronic structure, electrical, magnetic and optical properties, supraconductors, magnetic resonance, relaxation, spectroscopy  Head  2011 - 2019 
0031  University of Belgrade, Faculty of Mining and Geology
0038  University of Novi Sad, Faculty of Technical Sciences
0099  University of Nis, Faculty of Medicine
0106  University of Belgrade, Institute for Multidisciplinary Research
Abstract
The main objective of the project is the research on the magnetic and radionuclide labeled nanomaterials suitable for medical applications, including multifunctional nanomaterials based on radionuclide labeled magnetic nanopaticles (MNPs). The project will be realized through the following workpackages: - Design of nanomagnetic materials for magnetic resonance imaging (MRI) and magnetic hyperthermia (MH); - Design of new radionuclide labeled nanostructures for diagnostics and targeted radionuclide therapy (TRT) of malignant diseases; - Development of new radiopharmaceuticals based on nanostructured materials; - Research on multifunctional radionuclide labeled MNPs for simultaneous TRT–MRI and MH-TRT. The main projected outcomes can be subdivided as: i) Results of fundamental research ­ Introduction of reliable methods for controlled MNPs synthesis and functionalization; Identification of target candidates and suitable vectors for TRT. ii) Results of applied research ­ Synthesis of differently coated MNPs with targeted magnetic and biochemical characteristics; ­ Synthesis of different ferrofluids optimized for MRI and MH; ­ Development of radionuclide labeled vectors (functionalized NPs with different chelators and co-ligands). iii) Preclinical testing of drug candidates ­ In vitro testing of toxicity of synthesized NPs in cultured immune cells; In vivo studies of stability, biodistribution and therapeutic efficacy of functionalized radiolabeled NPs on small animals.
Views history
Favourite